Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 09/30/2019

Month EndAs of 09/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) -17.19 0.41 1.09 13.55 10.48
Fund with Sales Charge (%) (POP) -17.19 0.41 1.09 13.55 10.48
Quarter EndAs of 09/30/2019 1 Yr 3 Yr 5 Yr 10 Yr Since Inception Inception 09/15/1997
Fund without Sales Charge (%) (NAV) -17.19 0.41 1.09 13.55 10.48
Fund with Sales Charge (%) (POP) -17.19 0.41 1.09 13.55 10.48
NASDAQ Biotechnology Index (%) -18.45 1.10 1.81 14.19 10.87
S&P 500 Index (%) 4.25 13.40 10.84 13.24 7.48

Calendar Year Returns

2018 2017 2016 2015 2014 2013
Fund without Sales Charge (%) (NAV) -15.41 19.32 -16.82 5.89 34.50 69.49
Fund with Sales Charge (%) (POP) -15.41 19.32 -16.82 5.89 34.50 69.49
NASDAQ Biotechnology Index (%) -9.32 21.06 -21.68 11.42 34.32 65.97
S&P 500 Index (%) -4.38 21.83 11.96 1.38 13.69 32.39

Cumulative Total Returns [further-information] As of 09/30/2019

Month EndAs of 09/30/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 6.51 -17.19 1.23 5.57 256.42 798.72
Fund with Sales Charge (%) (POP) 6.51 -17.19 1.23 5.57 256.42 798.72
Quarter EndAs of 09/30/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 6.51 -17.19 1.23 5.57 256.42 798.72
Fund with Sales Charge (%) (POP) 6.51 -17.19 1.23 5.57 256.42 798.72
NASDAQ Biotechnology Index (%) 2.76 -18.45 3.32 9.39 276.85 872.33
S&P 500 Index (%) 20.55 4.25 45.80 67.27 246.74 390.39

After-Tax Average Annual Total Returns [further-information] As of 09/30/2019

Month EndAs of 09/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -18.09 -0.59 -0.25 12.34
Fund without Sales Charge (%) (NAV) After Shares Sold -9.97 0.12 0.58 11.10
Fund with Sales Charge (%) (POP) Before Shares Sold -18.09 -0.59 -0.25 12.34
Fund with Sales Charge (%) (POP) After Shares Sold -9.97 0.12 0.58 11.10
Quarter EndAs of 09/30/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -18.09 -0.59 -0.25 12.34
Fund without Sales Charge (%) (NAV) After Shares Sold -9.97 0.12 0.58 11.10
Fund with Sales Charge (%) (POP) Before Shares Sold -18.09 -0.59 -0.25 12.34
Fund with Sales Charge (%) (POP) After Shares Sold -9.97 0.12 0.58 11.10

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.72%
Net Expense Ratio [further-information] 0.65%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 10/31/2019 Updated Monthly, based on a 3-year period

Beta 1.08
Sharpe Ratio 0.29
Standard Deviation 22.39

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index